We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
Cap. Flow
+$59.9M
Cap. Flow %
4.93%
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$18.4M
2
NMRA icon
Neumora Therapeutics
NMRA
+$4.72M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.83M
4
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.67M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$3.3M

Top Sells

Rank Stock Value
1
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$1.96M
2
GSIE icon
Goldman Sachs ActiveBeta International Equity ETF
GSIE
+$906K
3
INTF icon
iShares International Equity Factor ETF
INTF
+$852K
4
AVUS icon
Avantis US Equity ETF
AVUS
+$644K
5
DISV icon
Dimensional International Small Cap Value ETF
DISV
+$589K

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.41%
2 Technology 7.75%
3 Healthcare 2.78%
4 Financials 1.79%
5 Communication Services 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RY icon
201
Royal Bank of Canada
RY
$283B
$371K 0.03%
3,490
+706
+25% +$72.6K
TGT icon
202
Target
TGT
$74.1B
$368K 0.03%
2,483
-31
-1% -$4.88K
RCL icon
203
Royal Caribbean
RCL
$74.7B
$366K 0.03%
2,298
+48
+2% +$6.9K
ETN icon
204
Eaton
ETN
$156B
$366K 0.03%
+1,167
New +$377K
UL icon
205
Unilever
UL
$140B
$365K 0.03%
5,902
+1,080
+22% +$63.8K
GILD icon
206
Gilead Sciences
GILD
$181B
$364K 0.03%
5,299
+608
+13% +$40.6K
VOD icon
207
Vodafone
VOD
$37.1B
$362K 0.03%
40,768
+6,712
+20% +$59.8K
SCHH icon
208
Schwab US REIT ETF
SCHH
$11.3B
$361K 0.03%
18,100
-16
-0.1% -$312
LRGF icon
209
iShares US Equity Factor ETF
LRGF
$3.71B
$360K 0.03%
6,473
+2
+0% +$107
IEMG icon
210
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
$360K 0.03%
6,722
-205
-3% -$10.8K
LHX icon
211
L3Harris
LHX
$48.9B
$358K 0.03%
1,595
+602
+61% +$130K
SAN icon
212
Banco Santander
SAN
$213B
$354K 0.03%
76,556
+24,048
+46% +$118K
ORLY icon
213
O'Reilly Automotive
ORLY
$71.6B
$353K 0.03%
5,010
+15
+0.3% +$1.04K
BN icon
214
Brookfield
BN
$92.3B
$347K 0.03%
12,534
+4,860
+63% +$135K
WFC icon
215
Wells Fargo
WFC
$262B
$345K 0.03%
5,804
+342
+6% +$20.2K
REGN icon
216
Regeneron Pharmaceuticals
REGN
$81.8B
$341K 0.03%
324
+21
+7% +$20.4K
T icon
217
AT&T
T
$178B
$340K 0.03%
17,805
+4,268
+32% +$74.2K
PM icon
218
Philip Morris
PM
$299B
$340K 0.03%
3,358
+285
+9% +$27.9K
C icon
219
Citigroup
C
$223B
$333K 0.03%
5,241
+431
+9% +$26.6K
ARW icon
220
Arrow Electronics
ARW
$10.4B
$331K 0.03%
2,745
+782
+40% +$99.9K
SHOP icon
221
Shopify
SHOP
$197B
$331K 0.03%
5,015
+114
+2% +$7.56K
IBM icon
222
IBM
IBM
$222B
$326K 0.03%
1,887
+567
+43% +$98.5K
ORAN
223
DELISTED
Orange
ORAN
$324K 0.03%
32,393
+18,034
+126% +$201K
SONY icon
224
Sony
SONY
$145B
$323K 0.03%
18,985
-3,185
-14% -$52.7K
RELX icon
225
RELX
RELX
$63.6B
$320K 0.03%
6,967
+659
+10% +$28.6K
7 8
9
10 11

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.

  • Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
  • Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
  • Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
  • Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
  • Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
  • Callan Capital opened 35 new positions and closed 18 in Q2 2024.
  • Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.

Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.